Clinical Trial Update: Tivozanib + Enzalutamide in Adv Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tivozanib in combination with enzalutamide for advanced prostate cancer was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Tivozanib (tivozanib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-07-16